Perfil
Emma Beausang is currently working as the VP-Regulatory Affairs & Quality Assurance at GH Research Plc.
Previously, she worked as the Vice President-Regulatory Affairs at Aerie Pharmaceuticals, Inc. Dr. Beausang holds a doctorate degree from UCL School of Pharmacy and an undergraduate degree from the University of Strathclyde.
Cargos activos de Emma Beausang
| Empresas | Cargo | Inicio |
|---|---|---|
| GH RESEARCH PLC | General Counsel | - |
Antiguos cargos conocidos de Emma Beausang.
| Empresas | Cargo | Fin |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | General Counsel | 01/12/2021 |
Formación de Emma Beausang.
| University of Strathclyde | Undergraduate Degree |
| UCL School of Pharmacy | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GH RESEARCH PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Emma Beausang
